TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
0.4000
+0.0860 (27.39%)
At close: Apr 24, 2025, 4:00 PM
0.4000
0.00 (0.00%)
After-hours: Apr 24, 2025, 7:55 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $9.34 million as of April 24, 2025. Its market cap has increased by 151.10% in one year.
Market Cap
9.34M
Enterprise Value
3.56M
1-Year Change
151.10%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $9.34M, a decrease of -80.50%. That is a compound annual growth rate of -35.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 9.34M | 297.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -52.59% |
| Dec 30, 2022 | 8.72M | -73.34% |
| Dec 31, 2021 | 32.72M | -31.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.92B |
| UnitedHealth Group | 385.48B |
| Johnson & Johnson | 380.39B |
| AbbVie | 303.95B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.28B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |